VG Innovations, LLC – Trademark Portfolio
Entity Type: 16
VG Innovations, LLC holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 10 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include SIJOIN, VERTELP, and VERTELOC. The owner is based in Winston-Salem, NC.
Suite 110
1399 Ashleybrook Lane
Winston-Salem, NC 27103
Showing of trademarks Trademarks
Trademark Classifications
VG Innovations, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does VG Innovations, LLC have?
VG Innovations, LLC has 12 U.S. trademarks filed with the USPTO. Of these, 4 registered, 7 abandoned, 1 cancelled.
What trademark classes does VG Innovations, LLC file in?
VG Innovations, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are VG Innovations, LLC's most well-known trademarks?
VG Innovations, LLC's registered trademark portfolio includes well-known marks such as SIJOIN, VERTELP, and VERTELOC. These are among 4 currently registered trademarks in the portfolio.
What is VG Innovations, LLC's trademark registration success rate?
VG Innovations, LLC has a 33% trademark registration rate, with 4 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.